Kopran Ltd. Schedules Board Meeting on May 19, 2026 to Consider FY26 Audited Results and Dividend

1 min read     Updated on 06 May 2026, 04:19 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Kopran Ltd. has scheduled a Board of Directors meeting on May 19, 2026, to consider and approve Standalone and Consolidated Audited Financial Results for the Quarter and Financial Year ended March 31, 2026. The board will also deliberate on the recommendation of a dividend, if any. The Trading Window, closed since April 1, 2026, will reopen 48 hours after the declaration of results. The intimation was filed on May 06, 2026, under Regulation 29(1) of the SEBI (LODR) Regulations, 2015.

powered bylight_fuzz_icon
39610177

*this image is generated using AI for illustrative purposes only.

Kopran Ltd. has informed the stock exchanges of an upcoming Board of Directors meeting scheduled for Tuesday, May 19, 2026, at its Registered Office. The intimation was filed on May 06, 2026, under Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Agenda

The Board meeting has been convened to consider and approve key financial and corporate matters. The following items are on the agenda:

  • Standalone and Consolidated Audited Financial Results for the Quarter and Financial Year ended March 31, 2026
  • Consideration and recommendation of Dividend, if any
Parameter: Details
Meeting Date: Tuesday, May 19, 2026
Venue: Registered Office
Results Period: Quarter and Financial Year ended March 31, 2026
Results Type: Standalone and Consolidated Audited
Dividend: To be considered, if any
Regulatory Reference: Regulation 29(1), SEBI (LODR) Regulations, 2015

Trading Window Update

Pursuant to the Company's Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information, the Trading Window for dealing in the securities of Kopran Ltd. has been closed since April 1, 2026. The Trading Window will reopen 48 hours after the declaration of the financial results.

The intimation was signed by Sunil Sodhani, Company Secretary & Compliance Officer (Membership No. FCS 3897), on behalf of Kopran Ltd.

Historical Stock Returns for Kopran

1 Day5 Days1 Month6 Months1 Year5 Years
-1.50%-1.59%+20.62%+2.25%-10.55%-14.84%

How has Kopran Ltd.'s revenue and profitability trended over FY2026 compared to FY2025, and what key business segments drove performance?

Will Kopran Ltd. announce a dividend for FY2026, and how does its dividend history reflect the company's capital allocation strategy?

How might Kopran Ltd.'s FY2026 financial results compare to peers in the Indian pharmaceutical sector amid evolving regulatory and pricing pressures?

Kopran Limited Publishes Merger Notice; Stakeholder Meetings on June 3

3 min read     Updated on 04 May 2026, 05:08 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Kopran Limited has published newspaper advertisements regarding the merger with Kopran Laboratories Limited following NCLT order dated April 9, 2026. Six stakeholder meetings are scheduled for June 3, 2026, through video conferencing with remote e-voting available from May 27 to June 2. The merger scheme under Companies Act, 2013 requires approval from all stakeholder categories and subsequent NCLT sanction.

powered bylight_fuzz_icon
39099485

*this image is generated using AI for illustrative purposes only.

Kopran Limited has published newspaper advertisements on May 2, 2026, in Free Press Journal (English) and Navshakti (Marathi) pursuant to the directions of the National Company Law Tribunal, Mumbai Bench, vide Order dated April 9, 2026. The publication serves as notice to members, secured creditors, and unsecured creditors for the approval of the Scheme of Amalgamation (Merger by Absorption) of Kopran Laboratories Limited (the Transferor Company) with Kopran Limited (the Transferee Company).

Meeting Schedule and E-Voting Details

The NCLT has convened six separate meetings for different stakeholder categories of both entities, all to be conducted through video conferencing and other audio-visual means on Wednesday, June 3, 2026. Remote e-voting facilities will be available from Wednesday, May 27, 2026, at 9:00 a.m. IST until Tuesday, June 2, 2026, at 5:00 p.m. IST.

Company Stakeholder Category Date Time (IST)
Kopran Limited Equity Shareholders June 3, 2026 10.00 a.m.
Kopran Limited Secured Creditors June 3, 2026 11.30 a.m.
Kopran Limited Unsecured Creditors June 3, 2026 1.00 p.m.
Kopran Laboratories Limited Equity Shareholders June 3, 2026 2.30 p.m.
Kopran Laboratories Limited Secured Creditors June 3, 2026 3.30 p.m.
Kopran Laboratories Limited Unsecured Creditors June 3, 2026 5.00 p.m.

Merger Framework and Key Dates

The proposed transaction involves a scheme of amalgamation through merger by absorption under Sections 230 to 232 of the Companies Act, 2013. Notices were dispatched to stakeholders on April 30, 2026, through email at registered addresses and via courier on May 2, 2026, where email service was not possible. The cut-off date for notice dispatch was April 24, 2026, while the cut-off date for e-voting is May 22, 2026.

Meeting Officials and Documentation

Ms. Nina Lath Gupta (Ex. IRS and Ex-MD, NFDI) has been appointed as Chairperson for the meetings, with Mr. Narayan Tulsiram Tati as alternate. Ms. Smita Vinayak Prabhu of M/s. Smita Prabhu & Associates has been appointed as Scrutinizer. Complete meeting notices, explanatory statements, and annexures are available on the company's websites at www.kopran.com and www.kopranlaboratories.com , as well as on BSE, NSE, and NSDL portals. The results will be announced within two working days from the conclusion of the meetings.

Regulatory Compliance

The announcement has been made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. The communication, signed by Company Secretary and Compliance Officer Sunil Sodhani, has been formally submitted to both BSE Limited and The National Stock Exchange of India Limited. The scheme, if approved at the NCLT-convened meetings, will be subject to subsequent approval of the Hon'ble NCLT, Mumbai Bench.

Source: None/Company/INE082A01010/1c833258-6a84-416c-a8f3-ade75f286715.pdf

Historical Stock Returns for Kopran

1 Day5 Days1 Month6 Months1 Year5 Years
-1.50%-1.59%+20.62%+2.25%-10.55%-14.84%

What share swap ratio has been proposed for Kopran Laboratories Limited shareholders, and how does it compare to the current market valuations of both entities?

How might the absorption of Kopran Laboratories Limited into Kopran Limited impact the combined entity's revenue, debt profile, and competitive positioning in the Indian pharmaceutical market?

If secured or unsecured creditors vote against the scheme, what alternative restructuring options could Kopran Limited pursue to achieve its consolidation objectives?

More News on Kopran

1 Year Returns:-10.55%